Kevin R Flaherty

 Kevin Flaherty
Professor of Internal Medicine
IRB Vice Chair and Associate Residency Program Director
Medical School
Email:
[email protected]
Available to mentor
Kevin R Flaherty
Kevin Flaherty
Professor
  • Recent Publications

  • Manage Your Profile

    • Recent Publications

     See All Publications
    • Journal Article
      Workplace Productivity Loss in Patients with Progressive Pulmonary Fibrosis: Data from the ILD-PRO Registry
      Shetty S, Swaminathan AC, Li P, Neely ML, Olson AL, Snyder LD, Whelan TPM, Walia R, Veeraraghavan S, Strek ME, Southern B, Liu G, Safdar Z, Russell T, Rosas I, Roman J, Ramaswamy M, Raj R, Porteous M, Paul T, Namen A, Morrison L, Maher TM, Mageto Y, Luckhardt TR, Lobo L, Lipchik R, Pinto-Plata V, Sanchez H, Lasky JA, Hewlett J, Gupta E, Kim HJ, Kebbe J, Kaner RJ, Hotchkin D, Hamblin M, Case AH, Gupta N, Gulati M, Fowler R, Flaherty KR, Fitzgerald J, Bemiss B, Dilling D, Condos R, Chardon D, Belperio JA, Beegle S, Bandyopadhyay D, Baker A. Lung, 2026 Dec 1; 204 (1): DOI:10.1007/s00408-026-00895-x
      PMID: 42201372
    • Journal Article
      Metabolomic profiling reveals distinct and shared biology in COPD and IPF
      Rosario A, Prince N, Madha-Krause S, Lutz SM, Hecker JE, Yun JH, Cho MH, Halu A, Washko GR, Sciurba FC, Barwick L, Limper AH, Flaherty KR, Criner GJ, Brown KK, Wise R, Martinez FJ, Bowler RP, Gerszten RE, Clish CB, Silverman EK, Kelly RS. Metabolomics, 2026 Oct 1; 22 (5): DOI:10.1007/s11306-026-02508-3
      PMID: 42631875
    • Journal Article
      Performance of age-adjusted whole genome sequencing telomere length in idiopathic pulmonary fibrosis
      Kim JS, Receveur B, Zhang D, Ma SF, Huang Y, McGroder C, Putman RK, Podolanczuk AJ, Rotter JI, Rich SS, Flaherty KR, Lee JS, Lasky JA, Raghu G, Murray S, Spino C, Martinez FJ, Oh A, Lynch DA, Humphries SM, Adegunsoye A, Oldham JM, Hunninghake GM, Garcia CK, Taub M, Mathias RA, Cho MH, Barr RG, Noth I, Mychaleckyj JC, Manichaikul A, Newton CA. American Journal of Respiratory and Critical Care Medicine, 2026 Oct 1; 212 (10): 2445 - 2454. DOI:10.1093/ajrccm/aamag259
      PMID: 42261270
    • Journal Article
      Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.
      Nathan SD, Smith P, Deng C, Golden J, Reynaud-Gaubert M, Farr G, Bregman B, Crossno PF, Harari S, Gupta N, Jouneau S, Adir Y, Molina-Molina M, Breytenbach N, Peterson L, Bell H, Zywot E, Rao Y, Flaherty KR, Cottin V, Behr J, TETON-1 and TETON-2 Trial Investigators . Am J Respir Crit Care Med, 2026 Sep 23; DOI:10.1093/ajrccm/aamag507
      PMID: 42776606
    • Proceeding / Abstract / Poster
      Effect of inhaled treprostinil dosing in patients with idiopathic pulmonary fibrosis enrolled in the TETON IPF program
      Cottin V, Nathan S, Flaherty K, Smith P, Deng C, Rao Y, Dunaway D, Zywot E, Davis K, Behr J. 2026 Oct 31; pa833 DOI:10.1183/13993003.congress-2026.pa833
    • Proceeding / Abstract / Poster
      Improvements in lung function among idiopathic pulmonary fibrosis patients treated with inhaled treprostinil
      Behr J, Flaherty K, Cottin V, Smith P, Deng C, Rao Y, Dunaway D, Zywot E, Davis K, Nathan S. 2026 Oct 31; oa3523 DOI:10.1183/13993003.congress-2026.oa3523
    • Proceeding / Abstract / Poster
      Late Breaking Abstract - The effect of inhaled treprostinil in patients with idiopathic pulmonary fibrosis using a win ratio analysis
      Nathan S, Cottin V, Smith P, Deng C, Rao Y, Davis K, Zywot E, Dunaway D, Behr J, Flaherty K. 2026 Oct 31; pa824 DOI:10.1183/13993003.congress-2026.pa824
    • Journal Article
      Progressive pulmonary fibrosis: a state-of-the-art review
      Cottin V, Brown K, Flaherty KR, Kolb M, Lynch DA, Oldham J, Valenzuela C, Wijsenbeek M, Wells AU. European Respiratory Journal, 2026 Sep 1; 68 (3): DOI:10.1183/13993003.01557-2025
      PMID: 42276742